|
|
|
|
 |
|||
|
|||
Immunocytochemical localization of human hepatic alanine: glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type 1
PJ Cooper, CJ Danpure, PJ Wise and KM Guttridge
Division of Clinical Cell Biology, Clinical Research Centre, Harrow, Middlesex, United Kingdom.
Primary hyperoxaluria type 1 (PH1) is an inherited disorder of glyoxylate metabolism caused by a deficiency of the hepatic peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT; EC 2.6.1.44) [FEBS Lett (1986) 201:20]. The aim of the present study was to investigate the intracellular distribution of immunoreactive AGT protein, using protein A-gold immunocytochemistry, in normal human liver and in livers of PH1 patients with (CRM+) or without (CRM-) immunologically crossreacting enzyme protein. In all CRM+ individuals, which included three controls, a PH1 heterozygote and a PH1 homozygote immunoreactive AGT protein was confined to peroxisomes, where it was randomly dispersed throughout the peroxisomal matrix with no obvious association with the peroxisomal membrane. No AGT protein could be detected in the peroxisomes or other cytoplasmic compartments in the livers of CRM- PH1 patients (homozygotes). The peroxisomal labeling density in the CRM+ PH1 patient, who was completely deficient in AGT enzyme activity, was similar to that of the controls. In addition, in the PH1 heterozygote, who had one third normal AGT enzyme activity, peroxisomal labeling density was reduced to 50% of normal.
Volume 36,
Issue 10,
pp. 1285-1294,
10/01/1988
Copyright © 1988 by The Histochemical Society
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Williams and G. Rumsby Selected Exonic Sequencing of the AGXT Gene Provides a Genetic Diagnosis in 50% of Patients with Primary Hyperoxaluria Type 1 Clin. Chem., July 1, 2007; 53(7): 1216 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Monico, S. Rossetti, H. A. Schwanz, J. B. Olson, P. A. Lundquist, D. B. Dawson, P. C. Harris, and D. S. Milliner Comprehensive Mutation Screening in 55 Probands with Type 1 Primary Hyperoxaluria Shows Feasibility of a Gene-Based Diagnosis J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1905 - 1914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Birdsey, J. Lewin, A. A. Cunningham, M. W. Bruford, and C. J. Danpure Differential Enzyme Targeting As an Evolutionary Adaptation to Herbivory in Carnivora Mol. Biol. Evol., April 1, 2004; 21(4): 632 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Ravirajan, Y. Wang, L. A. Matis, L. Papadaki, M. H. Griffiths, D. S. Latchman, and D. A. Isenberg Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody Rheumatology, April 1, 2004; 43(4): 442 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Milliner, J. T. Eickholt, E. J. Bergstralh, D. M. Wilson, and L. H. Smith Results of Long-Term Treatment with Orthophosphate and Pyridoxine in Patients with Primary Hyperoxaluria N. Engl. J. Med., December 8, 1994; 331(23): 1553 - 1558. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. J. Lumb and C. J. Danpure Functional Synergism between the Most Common Polymorphism in Human Alanine:Glyoxylate Aminotransferase and Four of the Most Common Disease-causing Mutations J. Biol. Chem., November 10, 2000; 275(46): 36415 - 36422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Holbrook and C. J. Danpure Molecular Basis for the Dual Mitochondrial and Cytosolic Localization of Alanine:Glyoxylate Aminotransferase in Amphibian Liver Cells J. Biol. Chem., January 11, 2002; 277(3): 2336 - 2344. [Abstract] [Full Text] [PDF]
|
|
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |